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        Introduction 
  Coordinated control of proliferation and differentiation of 
tissue-specifi  c stem cells is essential for proper morphogenesis of 
organs and tissues. At early stages of brain development, 
neuroepithelial progenitors expand by rapid cell divisions and gen-
erate a large number and diverse classes of neurons (  Caviness 
et al., 2003  ). After this early neurogenic period, the growth rate 
of progenitors gradually decreases, and they begin to preferen-
tially produce glia at late embryonic and early postnatal stages 
(  Sauvageot and Stiles, 2002  ;   Miller and Gauthier, 2007  ). Re-
cent studies have demonstrated that these developmental chan-
ges occur, at least in part, at the level of neural stem cells 
(NSCs;   Martens et al., 2000  ;   Qian et al., 2000  ;   Shen et al., 2006  ; 
  Fasano et al., 2007  ). Thus, self-renewal and cell fate choice of 
NSCs are coordinately controlled in a stage-dependent manner, 
but the mechanisms underlying such coordination remain 
poorly understood. 
  The helix-loop-helix-leucine zipper  –  type transcription 
factor family, comprising c-Myc, N-Myc, and   L-  Myc (herein 
collectively called Myc), is one of the best-characterized proto-
oncoproteins that plays a vital role in cell cycle control (  Grandori 
et al., 2000  ). The tumor suppressor p19 
ARF   was originally 
identifi  ed as the protein encoded by an alternative reading frame 
of the   p16 
INK4a     locus (  Lowe and Sherr, 2003  ). Although p16 
INK4a  
acts as a cyclin-dependent kinase inhibitor, p19 
ARF   attenuates 
the cell cycle progression via p53-dependent and -independent 
pathways (  Lowe and Sherr, 2003  ). In particular, recent studies 
have shown that p19 
ARF   inhibits Myc activity independently of 
its action in the p53 pathway (  Cleveland and Sherr, 2004  ;   Datta 
et al., 2004  ;   Qi et al., 2004  ). 
  Recent studies have shown that these cell cycle regulators 
participate in development of multiple organs (for review see 
  Murphy et al., 2005  ). Brain-specifi  c inactivation of   N-Myc   and 
  c-Myc   in mice has been shown to cause a profound defect in 
proliferation of granule cell precursors, cells committed to a 
T
he modes of proliferation and differentiation of neu-
ral stem cells (NSCs) are coordinately controlled 
during development, but the underlying mechanisms 
remain largely unknown. In this study, we show that the 
protooncoprotein Myc and the tumor suppressor p19 
ARF   
regulate both NSC self-renewal and their neuronal and 
glial fate in a developmental stage  –  dependent manner. 
Early-stage NSCs have low p19 
ARF   expression and retain 
a high self-renewal and neurogenic capacity, whereas 
late-stage NSCs with higher p19 
ARF   expression possess a 
lower self-renewal capacity and predominantly generate 
glia. Overexpression of Myc or inactivation of p19 
ARF   re-
verts the properties of late-stage NSCs to those of early-
stage cells. Conversely, inactivation of Myc or forced 
p19 
ARF   expression attenuates self-renewal and induces 
precocious gliogenesis through modulation of the respon-
siveness to gliogenic signals. These actions of p19 
ARF   in 
NSCs are mainly mediated by p53. We propose that op-
posing actions of Myc and the p19 
ARF    –  p53 pathway have 
important functions in coordinated developmental control 
of self-renewal and cell fate choices in NSCs.
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cells acquired a high gliogenic activity (Fig. S1, C – H, available at 
http://www.jcb.org/cgi/content/full/jcb.200807130/DC1). These 
results suggest that the properties of the same progenitor popu-
lation change over time during development. 
  Up-regulation of p19 
ARF   in late-stage NSCs 
  We sought to identify a molecular correlate for this develop-
mental change and found that the level of p19 
ARF   mRNA  is 
gradually up-regulated during development, an    20-fold  in-
crease in the developing forebrain between E13.5 and postnatal 
day (P) 2 (  Fig. 1 D   and Fig. S2 A, available at http://www.jcb
.org/cgi/content/full/jcb.200807130/DC1). Similarly, the expres-
sion of p19 
ARF   was low in neurospheres from early embryos, 
whereas its level was signifi  cantly higher in cells from late-stage 
and adult brains (4-fold and 20-fold, respectively;   Fig. 1, E and G  ). 
This up-regulated level of p19 
ARF   was comparable with those 
detected in   p53 
   /       mouse embryo fi  broblasts that have been used 
widely to study the function of p19 
ARF   (  Fig. 1 F   and Fig. S2 C). 
Although similar stage-dependent up-regulation was observed 
for mRNA for p16 
INK4a   in neurosphere culture, its expression 
was barely detectable in forebrain tissue in vivo except for very 
low expression in the adult subventricular zone (  Fig. 1 E   and not 
depicted). In contrast, the expression levels of three Myc mem-
bers and p53 were relatively constant during embryogenesis and 
in neurosphere culture (  Fig. 1, D and E  ). Like elsewhere in em-
bryos, Myc was highly expressed in proliferating cells in the 
developing brain (Fig. S1, A  –  B  ’  ). These results demonstrate 
that the expression level of p19 
ARF   is inversely correlated with 
the self-renewal and neurogenic activity of NSCs, and its up-
regulation parallels gliogenesis at late embryonic stages. 
  Antagonistic actions of Myc and p19 
ARF   
on NSC self-renewal and proliferation 
  Next, we asked whether Myc and p19 
ARF   regulate NSC self-
renewal. We used GFP-expressing retroviruses to modulate their 
activities in neurosphere culture (  Fig. 2 A  , inset). 
[ID]FIG2[/ID]  GFP 
+   and 
GFP 
      cells in the control virus  –  infected culture did not show 
signifi  cant difference in terms of the self-renewal or differentia-
tion capacity regardless of the stage of tissue used, indicating 
that virus-infected cells faithfully recapitulate the properties of 
the whole cell populations in neurospheres (  Nagao et al., 2007  ; 
unpublished data). Overexpression of c-Myc and N-Myc signif-
icantly enhanced self-renewal of early-stage (E13.5) NSCs, and 
conversely, a Myc-Mad fusion construct, which acts as a 
dominant-negative (dn) form of Myc ( Berns et al., 1997 ), markedly 
attenuated the neurosphere formation (  Fig. 2 A  ). c-Myc also 
augmented the otherwise very low self-renewal activity of cells 
derived from late-stage (E18.5) embryos and adults (  Fig. 2 B  ). 
A similar effect of Myc was observed in repeatedly passaged 
neurospheres (Fig. S1 C). Conversely, p19 
ARF   and p16 
INK4a  
strongly attenuated self-renewal of early-stage cells (  Fig. 2 A  ). 
No detectable increase in cell death occurred in p19 
ARF -  and 
p16 
INK4a  -overexpressing culture in the presence of growth fac-
tors (Fig. S3 D, available at http://www.jcb.org/cgi/content/full/
jcb.200807130/DC1), indicating that the observed decrease was 
not the result of accelerated cell death. 
specifi  c neuronal subtype in the cerebellum (  Knoepfl  er et al., 
2002  ;   Hatton et al., 2006  ;   Zindy et al., 2006  ). Recent studies 
have also demonstrated the involvement of p19 
ARF   and p53 in 
the maintenance of NSCs in the adult brain (  Bruggeman et al., 
2005  ;   Molofsky et al., 2005  ;   Gil-Perotin et al., 2006  ;   Meletis 
et al., 2006  ). However, to date, their roles in developmental con-
trol of NSCs remain unknown. 
  In this study, we provide evidence that Myc and the 
p19 
ARF    –  p53 pathway not only regulate NSC self-renewal and 
proliferation but also control their fate, namely transition from 
early-stage neurogenesis to late-stage gliogenesis during devel-
opment. We propose that mutually antagonistic actions of Myc 
and the p19 
ARF    –  p53 pathway are key mechanisms by which the 
mode of self-renewal and differentiation of NSCs are coordi-
nately controlled in a developmental stage  –  dependent manner. 
  Results 
  Developmental changes in the properties 
of NSCs 
  First, we used neurosphere culture to examine developmental 
changes in the properties of NSCs. In this in vitro assay, cells 
with a capacity for self-renewal form clonal colonies called 
neurospheres when seeded at a clonal density (10 
4   cells/ml) in 
methylcellulose matrix in the presence of FGF2 and EGF 
(  Martens et al., 2000  ;   Nagao et al., 2007  ). The frequency of 
primary neurosphere-forming cells represents the content of 
NSCs in a given tissue, whereas those after subsequent pas-
sages refl  ect the capacity of individual NSCs at a given devel-
opmental stage (  Martens et al., 2000  ;   Bruggeman et al., 2005  ; 
  Molofsky et al., 2005  ). 
  In agreement with previous studies (  Martens et al., 2000  ; 
  Fasano et al., 2007  ), cells capable of forming clonal neuro-
spheres were detectable in brains at various stages (  Fig. 1 A  ). 
[ID]FIG1[/ID]  
The vast majority (  >  95%) of these cells expressed Sox2 and 
nestin, markers for undifferentiated progenitors, whereas they 
were negative for markers for more advanced progenitors such 
as Mash1, Ngn2, and Prox1 (  Nagao et al., 2007  ; unpublished 
data). Thus, NSCs at different stages, which are selected based 
on the capacity for self-renewal, share some common proper-
ties. Nevertheless, their self-renewing capacity was quantita-
tively different; cells derived from early-stage (embryonic day 
[E] 13.5) rat embryos retained a high self-renewal capacity, 
whereas cells from late-stage (E18.5) forebrains and the sub-
ventricular zone of the adult brain showed progressively lower 
activities. The mode of their differentiation also changed devel-
opmentally. The majority (  >  97%) of neurospheres derived from 
early-stage (E13.5) embryos retained multipotency (  Fig. 1 C  ; 
  Nagao et al., 2007  ) and produced many more TuJ1 
+   neurons 
than glial fi  brillary acidic protein (GFAP 
+  ) astrocytes and O4 
+  
oligodendrocytes (  Fig. 1 B  ). In contrast, although late embry-
onic and adult cells are also multipotent, they preferentially 
generated astrocytes at the expense of neurons. These changes 
in vivo can be recapitulated in vitro. When neurospheres were 
serially passaged at a clonal density, their self-renewal and 
neurogenic capacities gradually decreased, and conversely, the 1245 MYC AND P19
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ies have shown the involvement of p19 
ARF   in the maintenance of 
NSCs in the postnatal and adult brain (  Bruggeman et al., 2005  ; 
  Molofsky et al., 2005  ). Our data further demonstrate its impor-
tant role in NSC self-renewal during development. 
  The formation of neurospheres involves both proliferation 
and self-renewal. Thus, the observed effect of Myc inactivation 
could be a secondary consequence of a proliferation defect. To 
test this possibility, forebrains were isolated from embryos 
obtained by crossing   c-Myc 
fl  ox/fl  ox     with   Foxg1-Cre   mice, and the 
cells were cultured in monolayer at a high cell density, the con-
dition in which NSCs and other progenitors can grow in both 
self-renewing and non  –  self-renewing modes of divisions. Cell 
proliferation was evaluated by labeling with BrdU for 48 h. 
No signifi  cant difference was observed between Cre 
+  ( c-Myc 
   /     ) 
and Cre 
      ( c-Myc 
f/f    ) cells (  Fig. 2 F  ), demonstrating that c-Myc 
inactivation does not result in a general proliferation detect. 
  We also quantifi  ed the overall growth rate of neurospheres 
and the size of individual spheres. Myc-expressing cells grew 
faster than control cells and formed larger clonal colonies, 
whereas p19 
ARF   had an opposite effect (Fig. S3, A  –  C and not 
depicted). However, neither Myc nor p19 
ARF   increased cell 
death in the presence of growth factors (Fig. S3 D). Thus, Myc 
and p19 
ARF   stimulated and attenuated, respectively, prolifera-
tion of NSCs. However, Myc increased not only the prolifera-
tion rate but also the frequency of cells capable of forming 
  We further examined the roles for Myc and p19 
ARF   using 
several mutant mice. Only 3.2   ±   5.3% (  n   = 3; P   <   0.01) of 
sphere-forming stem cells were detected in the forebrain of   
c-Myc 
   /       mice at E9.5 compared with the wild-type (WT) and 
heterozygous littermates (  Fig. 2 C  ). Such a severe reduction in 
the content of NSCs was much more profound than the decrease 
in the total number of cells in the mutant brain (    50% of the 
WT level). Furthermore, we used mice carrying a conditional 
allele of   c-Myc   ( c-Myc 
fl  ox/fl  ox   )  for  brain-specifi  c   c-Myc   deletion 
(  Trumpp et al., 2001  ). Acute inactivation in vitro by infection 
with Cre-expressing viruses markedly decreased the self-renewal 
activity of   c-Myc 
flox/flox     cells (  Fig. 2 D  ). Similarly, forebrain-
specifi  c inactivation in vivo by crossing   c-Myc 
fl  ox/fl  ox     and   Foxg1-Cre   
(  Hebert and McConnell, 2000  ) mice caused a severe reduction 
of NSCs (  Fig. 2 E  ), demonstrating a cell-autonomous require-
ment for c-Myc in NSCs. 
 p19 
ARF   had an opposite effect in late-stage cells. The low 
neurosphere-forming capacity of cells at P2 was markedly aug-
mented by inactivation of   p19 
ARF     (  Fig. 2 G  ;   Kamijo et al., 1997  ). 
Acute down-regulation of p19 
ARF   by short hairpin RNAs 
(shRNAs; short hairpin – p19-1 and -2;  Sage et al., 2003 ) also stimu-
lated self-renewal, indicating the direct action of p19 
ARF   on 
NSCs (  Fig. 2 H  ). However, inactivation of   p16 
INK4a     together 
with   p19 
ARF     (  Serrano et al., 1996  ) showed no additional effect 
compared with   p19 
ARF     single deletion (  Fig. 2 G  ). Previous stud-
  Figure 1.       Parallel developmental changes in the properties of NSCs and the expression level of p19 
ARF  .   (A  –  C) Developmental changes in the self-renewal 
and differentiation potential of NSCs at different stages. NSCs were isolated as neurospheres from rat forebrains at various stages, and their self-renewal 
activity (A) and differentiation potential (B) were examined. The photograph in C shows clonal neurospheres derived from E13.5 embryos stained for TuJ1 
(red), GFAP (blue), and O4 (green). (D  –  F) The mRNA level of various genes in freshly isolated rat forebrains (D) and neurospheres derived from those tis-
sues (E) is compared by RT-PCR using GAPDH as an internal control. In F, p19 
ARF   expression is compared between E11.5 and E18.5 mouse neurospheres 
and WT and   p53 
    /        mouse embryo ﬁ  broblasts. The sizes of PCR products are shown in base pairs below the gene names. (G) Developmental change in 
the p19 
ARF   mRNA expression level. *, P   <   0.01 compared with values in culture of E13.5 cells;  
$  , P   <   0.01 compared with values in culture of E18.5 cells. 
MEF, mouse embryo ﬁ  broblast. Error bars indicate mean + SD. Bar, 100   μ  m.     JCB • VOLUME 183 • NUMBER 7 • 2008  1246
suppressed neurogenesis and stimulated gliogenesis (  Fig. 3 A  ). 
[ID]FIG3[/ID]  
Moreover, the majority (89.3   ±   5.3%;   n   = 3) of Myc-expressing 
neurospheres maintained a high neurogenic capacity after re-
petitive passages (Fig. S1, D and F  –  H). Myc also conferred a 
high neurogenic activity to late-stage and adult NSCs (  Fig. 3 B  ). 
Conversely, overexpression of p19 
ARF   attenuated  neurogenesis 
and promoted astrogenesis in early-stage cells (  Fig. 3 A  ), 
whereas inactivation of   p19 
ARF     in vivo and acute down-regulation 
of p19 
ARF   by shRNAs in vitro had opposite effects in late-stage 
cells (  Fig. 3, C and D  ). Importantly, overexpression of p16 
INK4a  
or its inactivation together with p19 
ARF   had no signifi  cant effect 
(  Fig. 3, A and C  ), indicating that the action of p19 
ARF   on  differ-
entiation is not a mere consequence of attenuated self-renewal 
or proliferation. 
  Myc and p19 
ARF   modulate the response 
to gliogenic signals 
  Cytokines of the interleukin-6 family, including ciliary neuro-
trophic factor (CNTF), act as signals to induce astrocytes 
late in development (  Barnabe-Heider et al., 2005  ). We asked 
whether Myc and p19 
ARF   modulate the responsiveness to 
these gliogenic signals. Myc blocked the action of CNTF to 
self-renewing colonies as described above (  Fig. 2, A and B  ). 
Moreover, although p19 
ARF  -overexpressing cells could not 
form self-renewing colonies at a clonal density, they could 
grow as cell aggregates when cultured at a nonclonal high 
density (10 
5   cells/ml) without methylcellulose matrix. There-
fore, simple acceleration or attenuation of the growth rate 
does not account for the observed effects of Myc and p19 
ARF  
in the neurosphere formation assay. It is also unlikely that the 
action of Myc is attributable to immortalization. c-Myc  – 
expressing cells formed neurospheres only in the presence of 
growth factors (  Fig. 2 A  ). Moreover, transient (48 h) activa-
tion of Myc was suffi  cient to augment the self-renewing activ-
ity (Fig. S3 E). Altogether, these results demonstrate that Myc 
and p19 
ARF   regulate not only proliferation but also self-renewal 
of NSCs. 
  Regulation of NSC differentiation by Myc 
and p19 
ARF   
  Importantly, Myc and p19 
ARF   also regulated the differentiation 
potential of NSCs. In culture of early-stage cells, c-Myc and 
N-Myc signifi  cantly augmented differentiation of neurons at the 
expense of astrocytes and oligodendrocytes, whereas dn-Myc 
  Figure 2.       Regulation of NSC self-renewal by Myc and p19 
ARF  .   (A and B) Effects of retrovirus-mediated overexpression of Myc and p19 
ARF   on self-renewal. 
The frequency of neurosphere-forming cells among total virus-infected (GFP 
+  ) cells is compared using cells derived from different stages. Secondary (2nd) 
spheres were used for virus infection. Top insets show phase-contrast (left) and ﬂ  uorescent (right) images of GFP virus  –  infected (arrows) and uninfected 
(arrowheads) neurospheres. Bottom insets show larger neurospheres formed by c-Myc  –  expressing cells (right) compared with those of control cells. 
(C  –  E) Effects of inactivation of   c-Myc   on self-renewal. In C, the frequency of neurosphere-forming cells in the forebrain is compared with   c-Myc 
+/+    ,   c-Myc 
+/       , 
and   c-Myc 
    /        mice. In D and E,   c-Myc   was conditionally inactivated either by infection with Cre viruses in vitro (D) or by crossing with   Foxg1-Cre   mice using 
  c-Myc 
ﬂ  ox/ﬂ  ox     mice in vivo (E). The formation of neurospheres by cells with different genotypes is compared. (F) Effect of   c-Myc   inactivation on proliferation 
in monolayer. Forebrain neuroepithelial cells from   Foxg1-Cre  ;  c-Myc 
ﬂ  ox/+     and   Foxg1-Cre  ;  c-Myc 
ﬂ  ox/ﬂ  ox     embryos were cultured in monolayer and labeled with 
BrdU for 48 h in the presence of FGF2 and EGF. The percentage of BrdU 
+   cells among Cre 
+   (  c-Myc   inactivated) and Cre 
      (WT) cells was quantiﬁ  ed. 
(G and H) Effects of inactivation in vivo (G) and acute down-regulation in vitro (H) of   p19 
ARF     on self-renewal. In G, WT,   p19 
ARF    /       , and   p19 
ARF    /       ;  p16 
INK4a    /        
mice are compared. In H, short hairpin  –  p19-1 and -2 are retroviruses expressing shRNAs for p19 
ARF  , whereas short hairpin  –  Luc expresses shRNA for 
luciferase. *, P   <   0.01 compared with control virus  –  infected culture (A, B, D, and H) or   c-Myc 
+/+     (C),   Foxg1-Cre  ;  c-Myc 
ﬂ  ox/+     (E and F), and WT (G) mice. 
Error bars indicate mean + SD. Bars, 100   μ  m.     1247 MYC AND P19
  ARF   IN NEURAL STEM CELLS   • Nagao et al. 
exposure (  Fig. 5 A  , top,     /+), respectively, of growth factors. 
[ID]FIG5 [/ID]  
In contrast, p19 
ARF   expression did not show such a rapid re-
sponse to growth factors. However, prolonged exposure to 
growth factors during multiple passages led to marked up-
regulation of p19 
ARF   and down-regulation of c-Myc (  Fig. 5 A  , 
bottom; and Fig. S2 D). Thus, the expression of c-Myc and 
p19 
ARF   are regulated by growth factor signals either directly 
or indirectly (  Fig. 5 G  ). Interestingly, sustained high Myc ex-
pression blocked up-regulation of p19 
ARF   during serial pas-
sages (  Fig. 5 B  , left; and Fig. S2 E). c-Myc overexpression in 
late-stage cells also resulted in acute (  <  48 h) down-regulation 
of p19 
ARF  , indicating that the observed suppression was not 
the result of a genetic lesion of   p19 
ARF     (  Fig. 5 B  , right). Such 
Myc-dependent inhibition of p19 
ARF   in NSCs is in sharp con-
trast to oncogenic signal-induced up-regulation of p19 
ARF  
during tumorigenesis and cell death in other cell types (  Zindy 
et al., 1998  ). 
  The gliogenic signal CNTF also regulated the expression 
of Myc and p19 
ARF  . Continuous stimulation by CNTF resulted 
in marked up-regulation of p19 
ARF   and down-regulation of 
N-Myc (  Fig. 5 C   and Fig. S2 F). Thus, CNTF shifts the bal-
ance between Myc and p19 
ARF   toward a p19 
ARF -dominant  state 
during the clonal growth of NSCs. Upon induction of differen-
tiation, p19 
ARF   expression remained in GFAP 
+   astrocytes  but 
not TuJ1 
+   neurons, which is consistent with its strong astro-
genic action (  Fig. 5 D  ). Accumulation of p19 
ARF   in the nucleo-
lus was observed in these astrocytes as reported for other cell 
inhibit self-renewal in early-stage cells (  Fig. 4 A  ). 
[ID]FIG4[/ID]  Myc also 
suppressed CNTF-dependent stimulation of astrogenesis and 
inhibition of neurogenesis (  Fig. 4 B  ). Conversely, overexpres-
sion of p19 
ARF   mimicked the action of CNTF, and their combi-
nation further shifted the cells toward gliogenesis (  Fig. 4 B  ). 
  We also examined the interactions between CNTF signals 
and p19 
ARF   in late-stage cells with high p19 
ARF   expression. 
CNTF inhibited the already low self-renewal activity of cells 
derived from P2 mouse forebrains (a 46% reduction compared 
with control cells;   Fig. 4 C  ). However, inactivation of   p19 
ARF    
signifi  cantly attenuated this action. Similarly, CNTF-dependent 
astrogenesis was signifi   cantly attenuated by inactivation of 
  p19 
ARF     (  Fig. 4 D  ). Consequently, although   p19 
ARF   /       cells  still 
responded to CNTF, the self-renewal and gliogenic activity of 
CNTF-treated   p19 
ARF   /       cells recovered to the level in the un-
treated WT cells. In contrast, overexpression or inactivation of 
p16 
INK4a  did not alter the response to CNTF ( Fig. 4, B – D ). These 
results demonstrate that Myc and p19 
ARF   modulate the respon-
siveness to gliogenic signals. 
  Regulation of Myc and p19 
ARF   expression 
by growth factors and gliogenic signals 
  Next, we asked how the expression of Myc and p19 
ARF   is con-
trolled by extracellular signals. Like in many other cell types, 
c-Myc expression was maintained high in proliferating NSCs 
(  Fig. 5 A  , top, +/+), and its level was rapidly down-regulated 
and up-regulated upon removal (  Fig. 5 A  , top,    /   ) and re-
  Figure 3.       Regulation of neurogenesis and gliogenesis by Myc and p19 
ARF  .   (A and B) Effects of Myc and p19 
ARF   on differentiation of NSCs. The percent-
ages of neurons and glia among total virus-infected cells are compared. (C and D) Effects of inactivation in vivo (C) and acute down-regulation in vitro (D) 
of   p19 
ARF     on neurogenesis and gliogenesis. *, P   <   0.01 compared with control virus  –  infected culture (A, B, and D) or WT mice (C). Error bars indicate 
mean + SD.     JCB • VOLUME 183 • NUMBER 7 • 2008  1248
  p53 acts downstream of p19 
ARF   
  In addition to the direct regulation of Myc, p19 
ARF   exerts its ac-
tion through p53 in many cell types (  Lowe and Sherr, 2003  ). 
Thus, we next examined the role of p53 using   p53 
   /       mice  ( Guo 
et al., 2003  ). NSCs derived from late-stage   p53 
   /       mutants 
showed a higher self-renewal capacity (  Fig. 6 A  ) and produced 
fewer astrocytes and more neurons (  Fig. 6 B  ) compared with the 
WT and heterozygous cells. 
[ID]FIG6[/ID]  These phenotypes were reminis-
cent of those of   p19 
ARF   /       cells. Importantly, p19 
ARF   did not at-
tenuate self-renewal or stimulate astrogenesis in   p53 
   /       cells, 
indicating the essential role of p53 downstream of p19 
ARF   ( Fig.  6, 
A and B  ). 
  Next, we examined genetic epistasis between Myc and the 
p19 
ARF  – p53  pathway.  We  fi  rst tested whether the early lethal 
phenotype of   c-Myc   mutants (  Davis et al., 1993  ) can be rescued 
by concomitant inactivation of   p19 
ARF     or   p53  . However, we 
could not obtain embryos with a   c-Myc 
   /     ; p19 
ARF   /       or   c-Myc 
   /     ;
  p53 
   /       genotype that survived beyond E11.5 (Fig. S4, available 
at http://www.jcb.org/cgi/content/full/jcb.200807130/DC1), 
probably because of developmental defects in multiple organs 
other than the brain. 
  We then used neurosphere culture of late-stage cells 
that expressed both Myc and p19 
ARF   at substantial levels. As 
shown in   Fig. 6 A  , dn-Myc strongly attenuated the neuro-
sphere formation, and its action could not be abrogated by 
inactivation of   p53  , suggesting that p53 modulates self-renewal 
types (  Qi et al., 2004  ). These results demonstrate that Myc and 
p19 
ARF   are under the control of both growth factor and glio-
genic signals, which in turn act as cell-intrinsic modulators of 
the responsiveness of these extracellular signals. Moreover, 
given the previous reports that p19 
ARF   can inhibit the activity 
of Myc (  Datta et al., 2004  ;   Qi et al., 2004  ), the mutual antago-
nism between Myc and p19 
ARF   could be explained, at least in 
part, by their cross-regulation at the level of expression and 
activity (  Fig. 5 G  ). 
  Myc and p19 
ARF   regulate STAT3 
phosphorylation downstream of 
gliogenic signals 
  We further examined how Myc and p19 
ARF   regulate differentia-
tion of NSCs. Phosphorylation of signal transducer and activa-
tor transcription factor 3 (STAT3) is a crucial step in signal 
transduction downstream of CNTF (  Miller and Gauthier, 2007  ). 
We found that a high Myc activity decreased STAT3 phosphory-
lated at Y705 in response to CNTF, whereas p19 
ARF   overexpres-
sion had an opposite effect (  Fig. 5, E and F  ). Such changes were 
observed 48 h after infection with Myc and p19 
ARF   viruses  with 
no signifi  cant change in the level of total STAT3 proteins, indi-
cating that Myc and p19 
ARF   antagonize each other at the level or 
upstream of STAT3 phosphorylation. These results demonstrate 
that Myc and p19 
ARF   regulate gliogenesis, at least in part, 
through modulation of STAT3 signaling. 
  Figure 4.       Modulation of CNTF actions by Myc and p19 
ARF  .   (A) Block of CNTF-dependent inhibition of self-renewal by Myc. Control and c-Myc  –  expressing 
cells were subjected to the neurosphere formation assay in the presence of CNTF. (B) Effects of c-Myc, p19 
ARF  , and p16 
INK4a   on CNTF-dependent stimulation 
of astrogenesis (left) and inhibition of neurogenesis (right). Virus-infected cells were induced to differentiate in the presence of CNTF. (C and D) Effects of 
inactivation of   p19 
ARF     and   p16 
INK4a     on CNTF-dependent regulation of self-renewal (C) and differentiation (D). *, P   <   0.01 compared with mock-treated 
culture;  
$  , P   <   0.01 compared with control virus  –  infected culture (A and B) or WT mice (C and D). Error bars indicate mean + SD.     1249 MYC AND P19
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lated histone H3 compared with the WT (  Fig. 7, A, A  ’  , C, C  ’  , 
and G  ). 
[ID]FIG7 [/ID]  TuJ1 
+   neurons and Mash1 
+   progenitors were also re-
duced in the mutant forebrain (  Fig. 7, B, B  ’  , D  –  E  ’  , and G  ). 
Although a signifi  cant increase of activated caspase3 
+   dying 
cells was observed at E10.0 (  Fig. 7, F and F  ’    ), a substantial 
decrease of BrdU 
+   proliferative cells and TuJ1 
+   neurons  was 
already evident at E9.5, the stage before aberrant cell death 
began (  Fig. 7 G  ). Given the cell-autonomous effect of c-Myc 
in NSCs in vitro, a defi  ciency of NSCs is likely to be part of 
the reason for the observed defects in proliferation and neuro-
genesis in   c-Myc 
   /       forebrains. 
  Conditional inactivation of c-Myc late 
in development 
 Next, we examined the effect of late-stage inactivation of c-Myc 
on gliogenesis. We generated   c-Myc 
fl  ox/fl  ox   ; Nestin-CreER   mice  in 
which   c-Myc   can be inactivated at a specifi  c developmental 
stage in a tamoxifen-inducible manner (  Burns et al., 2007  ). 
We combined   CAG-CAT-EGFP   Cre reporter (  Nakamura et al., 
2006  ) to fate map c-Myc  –  inactivated cells as GFP 
+   cells.  We 
fi  rst set out the experimental paradigm to study the transition 
through inhibition of Myc activity or its downstream events. 
In contrast, both inhibition of neurogenesis and stimulation 
of astrogenesis by dn-Myc were reversed by   p53   inactiva-
tion, and conversely, altered cell fates in   p53 
   /       cells were 
rescued by dn-Myc (  Fig. 6 B  ). Thus, Myc affected the fate 
choice of NSCs in the absence of p53, and p53 modulated 
differentiation independently of Myc. These results suggest 
that Myc and the p19 
ARF  – p53  pathway  control  neurogenesis 
and gliogenesis through parallel pathways unlike their hier-
archical or linear relationship in regulating self-renewal 
( Fig.  6  C ). 
  Early neurogenic defect in   c-Myc 
    /         mice 
  The aforementioned in vitro data suggest that Myc controls 
NSC fate in a stage-dependent manner. To obtain in vivo evi-
dence supporting this idea, we fi  rst examined the consequence 
of c-Myc inactivation at early stages using   c-Myc 
   /       mice. 
  c-Myc 
   /       embryos die around E10.5 (  Davis et al., 1993  ), so 
their phenotypes were examined at E9.5 and E10.0. The mu-
tant had a smaller forebrain and contained a much smaller 
number of mitotic cells labeled with BrdU and phosphory-
  Figure 5.       Regulation of Myc and p19 
ARF   expression by growth factors and gliogenic signals.   (A) Growth factor  –  dependent regulation of Myc and p19 
ARF   
expression. (top) Neurospheres expanded in the presence of FGF2 and EGF for 3 d (+/+) were starved for 6 h and subsequently reexposed to growth 
factors for an additional 2 h (    /+) or left unexposed (    /    ). (bottom) Neurospheres were serially passaged, and the level of c-Myc and p19 
ARF   mRNAs 
was compared with the ﬁ  rst and ﬁ  fth spheres. (B) Suppression of p19 
ARF   expression by Myc. The cells examined are control and c-Myc virus  –  infected 
neurospheres derived from E13.5 (eighth passage; left) and E18.5 (second passage; right). p19 
ARF   was detected in DAPI 
+   cell nuclei of control (arrows) 
but not c-Myc (arrowheads) cells. (C) Regulation of p19 
ARF   and N-Myc by CNTF. Neurospheres were grown in the presence (+) or absence (    ) of CNTF 
for 7 d. (D) Expression of p19 
ARF   in astrocytes. Photographs show the localization of p19 
ARF   in the nucleoli of astrocytes (top, arrows) but not of neurons 
(bottom, arrowheads). The panels on the right show higher magniﬁ  cation views of the areas indicated by boxes on the left. (E and F) Effects of Myc and 
p19 
ARF   on CNTF-dependent STAT3 phosphorylation at Y705 (pSTAT3). (G) Model for the relationships of Myc and p19 
ARF   with extracellular signals and 
neuro/gliogenesis. Arrows and blunt-ended lines indicate stimulation and inhibition, respectively, either at the level of expression or function. The sizes 
of PCR products are shown in base pairs below the gene names. *, P   <   0.01 compared with mock-treated culture;  
$  , P   <   0.01 compared with control 
virus  –  infected culture. Error bars indicate mean + SD. Bars: (B) 25   μ  m; (D) 40   μ  m.     JCB • VOLUME 183 • NUMBER 7 • 2008  1250
larger percentage of   c-Myc  – inactivated  (  /  )  cells  became 
astrocytes in corresponding regions (  Fig. 7, N and O  ). We ob-
served no noticeable difference in the rate of proliferation, 
death, or neuronal and oligodendroglial differentiation be-
tween   c-Myc 
+/        and   c-Myc 
   /       GFP 
+   cells (unpublished data), 
arguing that c-Myc inactivation selectively affects astrocytes. 
These results demonstrate that conditional inactivation of   
c-Myc   at a late embryonic stage causes precocious differentia-
tion of astrocytes. 
  Delayed astrogenesis in   p19 
ARF     
mutant brains 
  Our in vitro data suggest that p19 
ARF   promotes gliogenesis at 
postnatal stages. We examined whether inactivation of   p19 
ARF    
results in delayed gliogenesis. In the WT, differentiation of 
GFAP 
+   and  S100   
+   astrocytes was detectable in widespread 
regions of the brain at P7. We observed much weaker expres-
sion of GFAP and S100     in comparable regions of   p19 
ARF     mu-
tants in both immunostaining (  Fig. 8, A  –  E  ’    ) and Western 
blotting (  Fig. 8 F  ). 
[ID]FIG8[/ID]  Quantitative analyses demonstrate that the 
number of astrocytes signifi  cantly decreased in many regions 
of the mutant brain (  Fig. 8 G  ). In contrast, the total cell num-
ber in the areas examined was indistinguishable between WT 
and mutant brains. No noticeable difference in the distribution 
pattern or density of neurons or dying cells was observed ei-
ther (unpublished data). Thus, inactivation of p19 
ARF   resulted 
in attenuated astrocyte differentiation in the postnatal brain as 
opposed to   c-Myc   inactivation. 
from neurogenesis to gliogenesis. When tamoxifen was admin-
istered to the control (  c-Myc 
fl o x / +   ; Nestin-CreER ; CAG-CAT-
EGFP  ) mice at E15.5, the majority (50  –  60%) of GFP 
+   cells 
became NeuN 
+   neurons at P3 (Fig. S5, available at http://www
.jcb.org/cgi/content/full/jcb.200807130/DC1). In contrast, in 
animals treated with tamoxifen at E16.5 or 17.5, the fraction of 
neurons among GFP 
+   cells was much smaller (7  –  9% at E16.5 
and 0.5  –  1.0% at E17.5 in the dorsolateral neocortex;   Fig. 7, 
I and J  ). These late-stage labeled cells were distributed through-
out the brain parenchyma (  Fig. 7, H and H  ’    ). In particular, GFP 
+  
cells located in areas near the lateral ventricle expressed Olig2, 
a marker for postnatal glial progenitors (  Fig. 7 K  ). It has been 
shown that these Olig2 
+   cells migrate to the forming gray and 
white matters and subsequently differentiate into astrocytes and 
oligodendrocytes postnatally (  Marshall et al., 2005  ). Thus, 
tamoxifen treatment at E16.5 and 17.5 allows us to detect the 
early phase of gliogenesis in vivo. 
  To compare the timing of astrocyte differentiation be-
tween   c-Myc 
+/        and   c-Myc 
   /       cells, we analyzed brains of 
tamoxifen-treated animals at P2 and 3, the stage when the ex-
pression of the astrocyte markers GFAP and S100     begin  to 
be detectable in many areas of the forebrain. At this early post-
natal stage, only a small fraction of   c-Myc   heterozygous (+/   ) 
GFP 
+   cells expressed GFAP and S100     (  Fig. 7, N and O  ). 
These cells were confi  ned to specifi  c regions such as the outer 
margin of the neocortex (  Fig. 7, L and L  ’    , arrowheads; and 
Fig. S5, C  ’   and D  ’  ), the hypothalamus (  Fig. 7, M and M  ’    , arrow-
heads), and the corpus callosum. In contrast, a signifi  cantly 
  Figure 6.       Involvement of p53 in Myc- and 
p19 
ARF  -dependent regulation of NSCs.   (A and B) 
Forebrain neurospheres derived from   p53 
+/+    , 
  p53 
+/       , and   p53 
    /        embryos were infected 
with control, p19 
ARF  , and dn-Myc viruses 
and were subsequently subjected to the self-
renewal (A) and differentiation (B) assays as 
described in   Figs. 2 and 3  . (C) Model for the 
relationships between Myc, p19 
ARF  , and p53. 
*, P   <   0.01 compared with control virus  –  infected 
culture with the same genotypes;  
$  , P   <   0.01 
compared with WT (+/+) cells infected with the 
same viruses. Error bars indicate mean + SD.     1251 MYC AND P19
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  Figure 7.       Impaired neurogenesis and gliogenesis caused by inactivation of   c-Myc   in vivo.   (A  –  G) Defects in proliferation and neurogenesis in forebrains 
of   c-Myc 
    /        mice at E9.5 and E10.0. In A  –  F  ’  , stained markers are shown in green, and cell nuclei were visualized with PI in red. Insets show higher mag-
niﬁ  cation views of boxed areas. BrdU was administered to pregnant dams 30 min before sampling. G shows a comparison of the percentages of marker-
positive cells (arrowheads) among total cells in the areas boxed in A  –  F  ’   between   c-Myc 
+/+    ,   c-Myc 
+/       , and   c-Myc 
    /        embryos. *, P   <   0.01 compared with 
  c-Myc 
+/+     mice. (H  –  O) Accelerated differentiation of astrocytes by conditional inactivation of   c-Myc   at late embryonic stages. Tamoxifen was administered 
to pregnant dams at E16.5 or E17.5, and pups were analyzed at P2 or 3.   c-Myc    –  inactivated cells were visualized as GFP 
+   cells using   CAG-CAT-EGFP   
Cre reporter. H and H  ’   show the distribution pattern of GFP 
+   cells in coronal sections of the forebrain. The arrows indicate migration of GFP 
+   cells from the 
subventricular zone (SVZ) toward the outer brain parenchyma. I  –  M  ’   show the phenotypes of GFP 
+   cells (arrowheads) in the neocortex (I  –  L  ’  ) and hypothala-
mus (M and M  ’  ) of   c-Myc 
ﬂ  ox/+    ;  Nestin-CreER  ;  CAG-CAT-EGFP   mice. The position of the areas shown in J  –  L  ’   is indicated by a box in I. N and O show the 
comparison of the percentages of GFAP 
+   and S100     
+   cells among GFP 
+   cells with   c-Myc 
ﬂ  ox/+     and   c-Myc 
ﬂ  ox/        genotypes in the regions indicated by boxes 
in H  ’  . *, P   <   0.01 compared with   c-Myc 
ﬂ  ox/+    ;  Nestin-CreER   cells. aCC, anterior corpus callosum; pCC, posterior corpus callosum; aCx, anterior neocortex; 
pCx, posterior neocortex; CC, corpus callosum; Cx, neocortex; HT, hypothalamus; LV, lateral ventricle; Sep, septum; St, striatum. Error bars indicate mean + SD. 
Bars: (A  –  F  ’  ) 200   μ  m; (A  –  F  ’  , insets) 40   μ  m; (H and H  ’  ) 500   μ  m; (I, L, and M) 100   μ  m; (J, L  ’  , and M  ’  ) 20   μ  m; (K) 50   μ  m.     JCB • VOLUME 183 • NUMBER 7 • 2008  1252
  Figure 8.       Attenuated astrocyte differentiation in early postnatal brains of   p19 
ARF     mutants.   (A  –  E  ’  ) GFAP staining of the WT (  p19 
ARF+/+    ) and   p19 
ARF    /        brains 
at P7. B  –  E  ’   show higher magniﬁ  cation views of the areas indicated by boxes in A. Differential staining patterns between the WT and mutant are highlighted 
by arrowheads. (F) Expression level of GFAP in various regions of   p19 
ARF+/+     and   p19 
ARF    /        mice. The level of GFAP proteins in the mutant relative to the WT 
(designated as 1.0) is indicated. (G) Comparison of the numbers of GFAP 
+   and S100     
+   astrocytes in speciﬁ  c regions of the brain. The locations of areas 
1  –  4 are indicated by boxes in A  ’  . (H) Model for the actions of Myc and the p19 
ARF    –  p53 pathway in developmental control of NSCs. Arrows at the top in-
dicate stimulation, and the thick horizontal arrow indicates transition from early- to late-stage cells. *, P   <   0.01 compared with the WT. CA1, hippocampal 
CA1 sector; Cx, neocortex; DG, dentate gyrus; F, ﬁ  mbria; Hipp, hippocampus; HT, hypothalamus; LV, lateral ventricle; Th, thalamus; SVZ, subventricular 
zone. Error bars indicate mean + SD. Bars: (A and A  ’  ) 1 mm; (B, B  ’  , D, and D  ’  ) 500   μ  m; (C, C  ’  , E, and E  ’  ) 200   μ  m.     1253 MYC AND P19
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  Discussion 
  Coordinated control of NSC self-renewal 
and differentiation by Myc and p19 
ARF   
  Myc and p19 
ARF   have been extensively studied in the context of 
tumorigenesis, cell death, and senescence of adult tissues and 
organs (  Grandori et al., 2000  ;   Lowe and Sherr, 2003  ). Recent 
studies have also begun to reveal their vital roles in normal de-
velopment (  Suzuki et al., 2008  ; for review see   Murphy et al., 
2005  ). In this study, we have demonstrated that Myc and p19 
ARF  
exert opposing actions in NSCs during brain development. 
Given their established roles in cell cycle control, their actions 
on self-renewal may not be an unexpected result. However, a 
novel fi  nding in this study is that these molecules also have pro-
found effects on neuronal and glial differentiation. At early em-
bryonic stages, p19 
ARF   expression remains low, whereas Myc 
expression is maintained high. Our data have shown that this 
Myc-dominant status links a high self-renewal and neurogen-
esis capacity in NSCs (  Fig. 8 H  ). As development proceeds, 
sustained mitogenic signals up-regulate p19 
ARF  , which in turn 
attenuates self-renewal and neurogenesis. Gliogenic signals fur-
ther up-regulate p19 
ARF  , thereby promoting the transition from 
neurogenesis to gliogenesis. This p19 
ARF  -dominant status ap-
pears to couple a low self-renewal and a high gliogenic capacity 
in late-stage NSCs. Thus, we suggest that opposing actions of 
Myc and p19 
ARF   coordinate the extent of self-renew and the tim-
ing of the production of neurons and glia during development. 
  Antagonistic actions of Myc and the 
p19 
ARF    –  p53 pathway in NSCs 
 Nervous  system – specifi  c inactivation of   N-Myc   and   c-Myc   has 
been shown to cause a defect in proliferation of cerebellar gran-
ule cell precursors (  Knoepfl  er et al., 2002  ;   Zindy et al., 2006  ). 
Thus, it has been proposed that Myc stimulates proliferation 
and inhibits differentiation in this specifi  c progenitor subtype 
that is already committed to a neuronal lineage (  Knoepfl  er 
et al., 2002  ). However, we found that Myc not only promotes 
self-renewal and proliferation but also neurogenesis in multi-
potent NSCs in the forebrain. Thus, Myc appears to play differ-
ent roles in distinct progenitor subtypes. 
  Like in well-studied cell cycle control, p19 
ARF   exerts  ac-
tions opposite to Myc in NSCs. p19 
ARF   has been shown to in-
hibit Myc activity independently of p53 (  Cleveland and Sherr, 
2004  ;   Datta et al., 2004  ;   Qi et al., 2004  ). However, our data sug-
gest that the action of p19 
ARF   is mainly mediated by p53 in 
NSCs. Thus, it remains unclear whether direct inhibition of 
Myc by p19 
ARF   occurs in NSCs. However, we found that Myc 
suppresses the growth signal  –  dependent expression of p19 
ARF . 
Moreover, they regulated the responsiveness to CNTF at the 
level of STAT3 phosphorylation in an opposite manner, sug-
gesting reciprocal interactions between Myc and p19 
ARF   at the 
level of their expression and/or function (  Fig. 5 G  ). 
  Interestingly, the mode of their antagonism appears to be 
distinct in controlling self-renewal and differentiation. Our data 
suggest that the p19 
ARF  – p53  pathway  attenuates  self-renewal 
through inhibition of Myc activity or its downstream events simi-
larly to cell cycle control (  Seoane et al., 2002  ;   Ho et al., 2005  ). 
In contrast, Myc and the p19 
ARF    –  p53 pathway appear to regu-
late differentiation at least in part through independent pathways. 
Our data have shown that the regulation of STAT3 phosphoryla-
tion is part of this mechanism, but other mechanisms are also 
likely to be involved. Recent studies have demonstrated the role 
for chromatin remodeling in the temporal control of gliogenesis 
(  Song and Ghosh, 2004  ;   Fan et al., 2005  ). Myc has been shown 
to regulate gene expression through chromatin remodeling 
( Knoepfl  er et al., 2006  ). Whether specifi  c epigenetic mecha-
nisms underlie Myc- and p19 
ARF  -dependent control of NSC fate 
remains to be investigated. 
 Recent studies have demonstrated important roles of many 
cell cycle regulators in stem cell self-renewal in adult organs 
(for review see   Bruggeman and van Lohuizen, 2006  ). For in-
stance, p16 
INK4a   and the polycomb group gene product Bmi-1 
have been shown to be involved in the maintenance of NSCs in 
the adult brain (  Bruggeman et al., 2005  ;   Molofsky et al., 2005  , 
  2006  ). Compared with these molecules, Myc and p19 
ARF   are 
unique in that it also regulates neuronal and glial fate choices. 
Interestingly, the expression of p16 
INK4a   was barely detectable in 
the developing forebrain unlike in the adult brain, whereas 
  robust up-regulation of p19 
ARF   was observed during embryo-
genesis. Thus, these two closely related cell cycle regulators 
appear to play distinct roles in NSCs at different stages; i.e., 
during development and in adults. 
  Myc and p19 
ARF   in temporal switch from 
neurogenesis to gliogenesis 
  Previous studies have shown that cell-intrinsic mechanisms 
regulate the transition from neurogenesis to gliogenesis by 
modulating the responsiveness to extracellular signals (  Qian 
et al., 2000  ;   Shen et al., 2006  ). Our data suggest that Myc and 
the p19 
ARF    –  p53 pathway are integral parts of such cell-intrinsic 
mechanisms. Myc attenuates the response to gliogenic signals 
by inhibiting up-regulation of p19 
ARF   and blocking STAT3 
phosphorylation. Thus, Myc suppresses precocious gliogenesis 
in early-stage NSCs by setting a high threshold for gliogenic 
signals. However, later in development, growth factor  –  induced 
p19 
ARF   antagonizes Myc, thereby lowering this threshold. Glio-
genic signals further up-regulate p19 
ARF  , which in turn aug-
ments gliogenesis via enhanced STAT3 phosphorylation. Thus, 
the p19 
ARF    –  p53 pathway is part of an intracellular positive feed-
back loop downstream of gliogenic signals, thereby contribut-
ing to a sharp transition from neurogenesis to gliogenesis at a 
specifi  c developmental stage. 
  Our results also explain apparently puzzling actions of 
growth factors. It has been shown that growth factors not only 
stimulate proliferation but also promote gliogenesis (  Viti et al., 
2003  ;   Song and Ghosh, 2004  ;   Nagao et al., 2007  ). However, 
other studies have shown a positive role for growth factor signals 
in neurogenesis (  Menard et al., 2002  ;   Samuels et al., 2008  ). Our 
data that both Myc and p19 
ARF   are regulated by growth factors 
can explain these dual actions. Although growth factors stimu-
late proliferation in early development, they also maintain a high 
Myc activity, which in turn supports neurogenesis. As develop-
ment proceeds, growth factors also up-regulate p19 
ARF ,  which  in 
turn promotes gliogenesis. Thus, the outcome of growth factor JCB • VOLUME 183 • NUMBER 7 • 2008  1254
  Materials and methods 
  Animals 
  All animal procedures were performed according to the guidelines and 
regulations of the Institutional Animal Care and Use Committee and the 
National Institutes of Health. The generation and genotyping of   c-Myc 
    /        
and   c-Myc 
ﬂ  ox/ﬂ  ox     (  Trumpp et al., 2001  ; maintained in an FVB/N back-
ground) and   Nestin-CreER   and   CAG-CAT-EGFP   mice (  Nakamura et al., 
2006  ;   Burns et al., 2007  ) were described previously.   p53 
    /        and   Foxg1-
Cre   mice (  Hebert and McConnell, 2000  ;   Guo et al., 2003  ) were pro-
vided by Y. Zheng and F. Guo (Cincinnati Children  ’  s Hospital Research 
Foundation, Cincinnati, OH) and S. McConnell (Stanford University, Stan-
ford, CA), respectively.   p19 
ARF    /        and   p19 
ARF    /       ;  p16 
INK4a    /        mutant mice 
(  Serrano et al., 1996  ;   Kamijo et al., 1997  ) were obtained from the Na-
tional Cancer Institute Mouse Models of Human Cancers Consortium and 
were maintained in a mixed background (129X1/SvJ   ×   C57BL/6 and 
129/Sv   ×   C57BL/6, respectively). To induce Cre activity in   c-Myc 
ﬂ  ox/       ;
  Nestin-CreER;CAG-CAT-EGFP   triple transgenic mice, a single dose of 
tamoxifen (Sigma-Aldrich) dissolved in maize oil (5 mg/40 g of body 
weight) was administered to pregnant dams on the indicated embryonic 
days. Embryos and pups of these mice and WT Sprague-Dawley rats 
were collected from timed pregnant females. Adult brains were obtained 
from 7  –  8-wk-old animals. 
  Cell culture 
  Neurosphere culture was performed as described previously (  Nagao et al., 
2007  ;   Sugimori et al., 2007  ) with some modiﬁ  cations. Embryos and pups 
were collected from timed pregnant rats or mice and placed in an artiﬁ  cial 
cerebrospinal ﬂ  uid (124 mM NaCl, 5 mM KCl, 1.3 mM MgCl  2  , 2 mM 
CaCl  2  , 26 mM NaHCO  3  , and 10 mM   D-  glucose). The forebrain was re-
moved from the rest of the embryos under a dissection microscope (SV-11; 
Carl Zeiss, Inc.). For samples derived from E18.5 embryos or later stages, 
brains were removed from the skull, and coronal sections were prepared 
either manually or using rodent brain matrix (ASI Instruments). Thin tissue 
strips near the lateral ventricles (    100-  μ  m thick from the adult brain) were 
further obtained from these coronal slices. The resultant tissue was dissoci-
ated by incubation in a low Ca 
2+   and high Mg 
2+   artiﬁ  cial cerebrospinal 
ﬂ  uid (124 mM NaCl, 5 mM KCl, 3.2 mM MgCl  2  , 0.1 mM CaCl  2  , 26 mM 
NaHCO  3  , 10 mM   D-  glucose, 100 U/ml penicillin, and 100   μ  g/ml strepto-
mycin [Mediatech]) containing 0.05% (wt/vol) trypsin (Sigma-Aldrich), 
0.67 mg/ml hyaluronidase (Sigma-Aldrich), and 0.1 mg/ml deoxyribonu-
clease I (Roche) at 37  °  C for 10 min. Subsequently, trypsin was neutralized 
with 0.7 mg/ml ovamucoid (Sigma-Aldrich), and the resultant tissue suspen-
sion was triturated mechanically to yield a single-cell suspension. The cells 
were ﬁ  ltered through a 40-  μ  m sterile nylon mesh (BD) and washed twice 
with a basal medium (1:1 mixture of DME and F-12 medium [Invitrogen] 
containing 100 U/ml penicillin and 100   μ  g/ml streptomycin). Numbers of 
viable cells were determined by staining with trypan blue (Sigma-Aldrich). 
  In experiments using monolayer culture, cells isolated from embryos 
with speciﬁ  c genotypes were directly seeded on 100   μ  g/ml poly-  D  -lysine 
(Sigma-Aldrich)  –  coated glass chambers at a density of 6   ×   10 
4   cells/cm 
2   
in the basal medium supplemented with the B-27 Supplement (Invitrogen), 
20 ng/ml bovine FGF2 (R  &  D Systems), 20 ng/ml mouse EGF (Roche), 
2   μ  g/ml heparin (molecular weight of 3,000; Sigma-Aldrich), and 1 mg/ml 
bovine serum albumin (Sigma-Aldrich). Dividing cells were labeled with 
1   μ  M BrdU (Sigma-Aldrich) for 48 h. 
  To determine the frequency of self-renewing NSCs in a given tissue, 
dissociated single cells were directly seeded in a medium containing meth-
ylcellulose matrix at a density of 10 
4   viable cells/ml. To manipulate cells by 
virus infection, primary neurospheres were dissociated at day 2 after seed-
ing and were replated to yield secondary spheres. The cells were har-
vested at day 4 and subjected to retrovirus infection by incubating with 
high titer virus stock to yield 30  –  60% infection efﬁ  ciency. These virus-
infected secondary spheres were used for self-renewal and differentiation 
assays unless otherwise stated. For multiple passages of neurospheres, 
clonal colonies formed by virus-infected cells in methylcellulose matrix were 
recovered, dissociated to single cells by trypsin, and seeded again in the 
medium containing methylcellulose. The same procedure was repeated to 
yield serially passaged spheres. The number of passage used in a speciﬁ  c 
set of experiments is indicated in the ﬁ  gure legends. We conﬁ  rmed the 
clonal nature of neurospheres formed under the aforementioned conditions 
using culture infected with GFP-expressing retroviruses; all clones were 
composed entirely of either GFP 
+   or GFP 
      cells but not both. 
  To induce differentiation of neurons and glia, cells were seeded onto 
poly-  D  -lysine  –  coated chambers as either individual clonal colonies (at a 
stimulation changes depending on whether NSCs are at the 
Myc-dominant early stage or p19 
ARF  -dominant late stage. 
  In vivo roles for Myc and p19 
ARF   in 
brain development 
  Inactivation of   N-Myc   and   c-Myc   using   Nestin-Cre   has been re-
ported to cause no severe morphological defects of the forebrain 
except for a substantial reduction in its size (  Knoepfl  er et al., 
2002  ;   Hatton et al., 2006  ;   Zindy et al., 2006  ). We observed a 
similar small brain phenotype in   Foxg1-Cre ; c-Myc 
fl  ox/fl  ox     mice 
(our unpublished data). One reason for this mild defect could be 
that multiple Myc family members share redundant functions. It 
could also be attributable to incomplete recombination of con-
ditional Myc alleles. Recombined   c-Myc 
   /       cells have a sub-
stantial growth disadvantage over nonrecombined cells, and 
thus, their defi  ciency could be easily masked by compensatory 
proliferation of WT cells. In fact, when their self-renewal activ-
ity was assessed at the single-cell level, c-Myc  –  inactivated cells 
showed a profound defi  ciency in vitro. Moreover, the forebrain 
of   c-Myc 
   /       mutants showed a severe neurogenic defect at an 
early stage. To overcome the problem of incomplete inactiva-
tion, we fate mapped Myc-inactivated cells as GFP 
+   cells  in 
late-stage   c-Myc   deletion experiments. Such studies have dem-
onstrated that   c-Myc   inactivation at the perinatal stage results in 
precocious differentiation of astrocytes. 
  It has been reported that   p19 
ARF     mutants show no obvious 
defect in brain development or in bulk culture of neurospheres 
at a high density (  Bachoo et al., 2002  ). No defect in early devel-
opment is reasonable given the very low expression of p19 
ARF   in 
the brain at early stages. However, we found that when NSCs 
were selectively expanded at a clonal density, cells from 
  p19 
ARF   /       mice at a late stage had a signifi  cantly lower gliogenic 
activity compared with the WT. Moreover, differentiation of 
astrocytes was signifi  cantly delayed or attenuated at the postnatal 
stage in   p19 
ARF     mutants. Notably, this phenotype is reminiscent 
of that of mice carrying a loss of function mutation of cardio-
tropin-1, the major STAT3-dependent gliogenic cytokine in the 
developing forebrain (  Barnabe-Heider et al., 2005  ). Together, 
these results support the idea that Myc and p19 
ARF   play impor-
tant roles in controlling neurogenesis and gliogenesis in vivo. 
  Common mechanisms for stem cell 
regulation in development, cancer, 
and aging 
  Previous studies have established the crucial roles for Myc and 
the p19 
ARF    –  p53 pathway in tumorigenesis and senescence of 
adult tissues and organs (  Grandori et al., 2000  ;   Lowe and Sherr, 
2003  ). It is particularly noteworthy that they are involved in 
various types of brain tumors ( Zhu and Parada, 2002 ). Our study 
has now revealed their novel roles in brain development. A re-
cently emerging idea is that deregulation and/or dysfunction of 
stem cells account for cancer and aging (  Clarke and Fuller, 
2006  ). Thus, understanding of the mechanisms underlying the 
control of stem cells in normal development has become in-
creasingly important. We suggest that mutually antagonistic ac-
tions of Myc and the p19 
ARF  – p53  pathway  are  key  mechanisms 
common for development, cancer, and aging of the brain. 1255 MYC AND P19
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rounded by GFAP 
+   or S100     
+   cytoplasm in deﬁ  ned areas (400   μ  m   ×   
280   μ  m = 0.112 mm 
2  ). From each animal, two to three (  c-Myc   mutant 
mice) or two to ﬁ  ve (  p19 
ARF     mice) coronal sections were chosen to cover 
comparable regions of the anterior and posterior parts of the forebrain. 
To maintain the consistency of staining results and avoid possible vari-
ability of developmental stages among litters, three to ﬁ  ve pairs of the 
WT and mutant embryos or pups derived from independent crossings 
were examined. 
  Western blot analysis 
  The expression of pSTAT3-Y705 and GFAP was examined by Western 
blot analyses as described previously (  Nagao et al., 2007  ) using the fol-
lowing antibodies: pSTAT3-Y705 (rabbit [1:1,000]; Cell Signaling Tech-
nology), STAT3 (mouse [1:2,500]; BD), and GFAP (mouse [1:1,000]; 
Millipore).     -Tubulin (mouse [1:1,000]; Sigma-Aldrich) and lamin B 
(goat [1:200]; Santa Cruz Biotechnology, Inc.) were used as internal 
controls. The relative expression level among samples was compared by 
analyzing digital images of blots using ImageJ software (National Insti-
tutes of Health). 
  RT-PCR 
  RNAs were isolated using the RNeasy kit (QIAGEN). The mRNA expres-
sion level was quantiﬁ  ed using Opticon DNA Engine (Bio-Rad Laborato-
ries), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used 
as an internal control. The following sense and antisense primers were 
used for RT-PCR and gel imaging (ampliﬁ  ed PCR product size is given in 
parentheses): rat c-Myc, 5    -TCCTGTACCTCGTCCGATTC-3     and 5    -ACAT-
GGCACCTCTTGAGGAC-3     (284 bp); rat N-Myc, 5    -  ACCAGCGCTGTG-
GTCACTA  -3     and 5    -  GTCTTGGGGCGTACAGTGAT  -3     (263 bp); rat   
  L  -  Myc, 5    -  AAGCTTGGGGCAGGAATTAT  -3     and 5    -  GTCTCTTCTCCACC-
GTCACC  -3     (297 bp); rat p19 
ARF  , 5    -  ACCCCAAGTGAGGGTTTTCT-3       
and 5    -GCACCATAGGAGAGCAGGAG-3     (193 bp); mouse p19 
ARF  , 
5    -GTCGCAGGTTCTTGGTCACT-3     and 5    -CGAATCTGCACCGTAGTTGA-3     
(246 bp); rat p16 
INK4a  , 5    -GAACACTTTCGGTCGTACCC-3     and 5    -CCCAGC-
GGAGGAGAGTAGAT-3     (292 bp); rat p53, 5    -TTTGAGGTTCGTGTTT-
GTGC-3     and 5    -CCTCATTCAGCTCTCGGAAC-3     (232 bp); and rat and 
mouse GAPDH, 5    -  ACCACAGTCCATGCCATCAC-3       and 5    -  TCCACCACC-
CTGTTGCTGTA  -3     (452 bp). 
  For quantitative RT-PCR using Opticon DNA Engine, the foll  owing sense 
and antisense primers were used: rat c-Myc, 5    -AAAGGCCCCCAAGG-
TAGTTA-3     and 5    -CTCGCCGTTTCCTCAGTAAG-3    ; rat N-Myc, 5    -  AGG-
CAGTCACCACTTTCACC  -3     and 5    -  GTTGTGTTGCTGATGGA  TGG  -3    ; 
rat p19 
ARF  , 5    -  ACCCCAAGTGAGGGTTTTCT-3       and 5    -GATCCTCTCTG-
GCCTCAACA-3    ; mouse p19 
ARF  , 5    -GCTCTGGCTTTCGTGAACAT-3     and 
5    -TGAGCAGAAGAGCTGCTACG-3    ; and rat and mouse GAPDH, 5    -  AAG-
GGCTCATGACCACAGTC-3       and 5    -  GGATGCAGGGATGATGTTCT  -3    . 
  Online supplemental material 
  Fig. S1 shows Myc-dependent regulation of self-renewal and differentiation 
during serial passages of neurospheres. Fig. S2 shows developmental and 
extracellular signal-dependent changes in the expression level of Myc and 
p19 
ARF  . Fig. S3 shows modulation of cell growth and death by c-Myc and 
p19 
ARF  . Fig. S4 shows failure of rescue of the early lethality of   c-Myc 
    /        
mutation by inactivation of   p19 
ARF     and   p53  . Fig. S5 shows stage-dependent 
genetic labeling of neural progenitors using   Nestin-CreER  ;  CAG-CAT-EGFP   
mice. Online supplemental material is available at http://www.jcb.org/
cgi/content/full/jcb.200807130/DC1. 
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